カテゴリー： GlobalInfoResearch, 世界

トキソイドワクチンの世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）

【英語タイトル】Global Toxoid Vaccines Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

GlobalInfoResearchが出版した調査資料（GIR9101145）・商品コード：GIR9101145
・発行会社（調査会社）：GlobalInfoResearch
・発行日：2019年9月9日（※2024年版があります。お問い合わせください）
・ページ数：119
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール
・調査対象地域：グローバル
・産業分野：製薬・医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥515,040見積依頼/購入/質問フォーム
Multi User（10名様閲覧用）USD5,220 ⇒換算￥772,560見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,030,080見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
本調査レポートは、トキソイドワクチンの世界市場について調べ、まとめました。種類別セグメントは、一価破傷風トキソイド（TT）、ジフテリア、破傷風、百日咳（DTaP）、ジフテリアおよび破傷風（DT）等、用途別セグメントは、病院および診療所、政府機関、研究、その他等に区分しました。トキソイドワクチンの世界市場概観、メーカー動向、メーカー別トキソイドワクチンシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。
・トキソイドワクチンの市場概観
・トキソイドワクチンの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等）
・トキソイドワクチンの企業別販売動向、市場シェア、市場集中度、競争動向
・トキソイドワクチンの世界市場規模
・トキソイドワクチンの北米市場分析（アメリカ、カナダ、メキシコ等）
・トキソイドワクチンのアメリカ市場規模推移
・トキソイドワクチンのカナダ市場規模推移
・トキソイドワクチンのメキシコ市場規模推移
・トキソイドワクチンのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）
・トキソイドワクチンのドイツ市場規模推移
・トキソイドワクチンのイギリス市場規模推移
・トキソイドワクチンのロシア市場規模推移
・トキソイドワクチンのアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等）
・トキソイドワクチンの日本市場規模推移
・トキソイドワクチンの中国市場規模推移
・トキソイドワクチンの韓国市場規模推移
・トキソイドワクチンのインド市場規模推移
・トキソイドワクチンの東南アジア市場規模推移
・トキソイドワクチンの南米市場分析（ブラジル、アルゼンチン等）
・トキソイドワクチンの中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等）
・トキソイドワクチンの種類別分析/販売量、売上、市場シェア（一価破傷風トキソイド（TT）、ジフテリア、破傷風、百日咳（DTaP）、ジフテリアおよび破傷風（DT））
・トキソイドワクチンの用途別分析/市場規模（病院および診療所、政府機関、研究、その他）
・トキソイドワクチンの市場予測2019年-2024年（地域別予測、種類別予測、用途別予測）
・トキソイドワクチンの販売チャネル・代理店・貿易業者・ディーラー分析
【レポートの概要】

For bacteria that secrete toxins, or harmful chemicals, a toxoid vaccine might be the answer. These vaccines are used when a bacterial toxin is the main cause of illness. Scientists have found that they can inactivate toxins by treating them with formalin, a solution of formaldehyde and sterilized water. Such “detoxified” toxins, called toxoids, are safe for use in vaccines.
When the immune system receives a vaccine containing a harmless toxoid, it learns how to fight off the natural toxin. The immune system produces antibodies that lock onto and block the toxin. Vaccines against diphtheria and tetanus are examples of toxoid vaccines.

Scope of the Report:
The worldwide market for Toxoid Vaccines is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Toxoid Vaccines in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
GlaxoSmithKline
Merck
Pfizer
Sanofi Pasteur
AstraZeneca
Bharat Biotech
Shenzhen Kangtai Biological Products
Valeant Pharmaceuticals
Emergent Biosolutions
Astellas Pharma
Panacea Biotec

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Monovalent Tetanus Toxoid (TT)
Diphtheria
Tetanus
Pertussis (DTaP)
Diphtheria and Tetanus (DT)

Market Segment by Applications, can be divided into
Hospitals And Clinics
Government Organizations
Research
Others

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Toxoid Vaccines product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Toxoid Vaccines, with price, sales, revenue and global market share of Toxoid Vaccines in 2017 and 2018.
Chapter 3, the Toxoid Vaccines competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Toxoid Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Toxoid Vaccines market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Toxoid Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.

【レポートの目次】

Table of Contents

1 Market Overview
1.1 Toxoid Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 Monovalent Tetanus Toxoid (TT)
1.2.2 Diphtheria
1.2.3 Tetanus
1.2.4 Pertussis (DTaP)
1.2.5 Diphtheria and Tetanus (DT)
1.3 Market Analysis by Applications
1.3.1 Hospitals And Clinics
1.3.2 Government Organizations
1.3.3 Research
1.3.4 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 GlaxoSmithKline
2.1.1 Business Overview
2.1.2 Toxoid Vaccines Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 GlaxoSmithKline Toxoid Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Merck
2.2.1 Business Overview
2.2.2 Toxoid Vaccines Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Merck Toxoid Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Pfizer
2.3.1 Business Overview
2.3.2 Toxoid Vaccines Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Pfizer Toxoid Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Sanofi Pasteur
2.4.1 Business Overview
2.4.2 Toxoid Vaccines Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Sanofi Pasteur Toxoid Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 AstraZeneca
2.5.1 Business Overview
2.5.2 Toxoid Vaccines Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 AstraZeneca Toxoid Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Bharat Biotech
2.6.1 Business Overview
2.6.2 Toxoid Vaccines Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Bharat Biotech Toxoid Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Shenzhen Kangtai Biological Products
2.7.1 Business Overview
2.7.2 Toxoid Vaccines Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Shenzhen Kangtai Biological Products Toxoid Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 Valeant Pharmaceuticals
2.8.1 Business Overview
2.8.2 Toxoid Vaccines Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Valeant Pharmaceuticals Toxoid Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 Emergent Biosolutions
2.9.1 Business Overview
2.9.2 Toxoid Vaccines Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Emergent Biosolutions Toxoid Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 Astellas Pharma
2.10.1 Business Overview
2.10.2 Toxoid Vaccines Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Astellas Pharma Toxoid Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.11 Panacea Biotec
2.11.1 Business Overview
2.11.2 Toxoid Vaccines Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Panacea Biotec Toxoid Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Toxoid Vaccines Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Toxoid Vaccines Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Toxoid Vaccines Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Toxoid Vaccines Manufacturer Market Share in 2018
3.3.2 Top 6 Toxoid Vaccines Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Toxoid Vaccines Market Analysis by Regions
4.1 Global Toxoid Vaccines Sales, Revenue and Market Share by Regions
4.1.1 Global Toxoid Vaccines Sales and Market Share by Regions (2014-2019)
4.1.2 Global Toxoid Vaccines Revenue and Market Share by Regions (2014-2019)
4.2 North America Toxoid Vaccines Sales and Growth Rate (2014-2019)
4.3 Europe Toxoid Vaccines Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Toxoid Vaccines Sales and Growth Rate (2014-2019)
4.5 South America Toxoid Vaccines Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Toxoid Vaccines Sales and Growth Rate (2014-2019)
5 North America Toxoid Vaccines by Country
5.1 North America Toxoid Vaccines Sales, Revenue and Market Share by Country
5.1.1 North America Toxoid Vaccines Sales and Market Share by Country (2014-2019)
5.1.2 North America Toxoid Vaccines Revenue and Market Share by Country (2014-2019)
5.2 United States Toxoid Vaccines Sales and Growth Rate (2014-2019)
5.3 Canada Toxoid Vaccines Sales and Growth Rate (2014-2019)
5.4 Mexico Toxoid Vaccines Sales and Growth Rate (2014-2019)
6 Europe Toxoid Vaccines by Country
6.1 Europe Toxoid Vaccines Sales, Revenue and Market Share by Country
6.1.1 Europe Toxoid Vaccines Sales and Market Share by Country (2014-2019)
6.1.2 Europe Toxoid Vaccines Revenue and Market Share by Country (2014-2019)
6.2 Germany Toxoid Vaccines Sales and Growth Rate (2014-2019)
6.3 UK Toxoid Vaccines Sales and Growth Rate (2014-2019)
6.4 France Toxoid Vaccines Sales and Growth Rate (2014-2019)
6.5 Russia Toxoid Vaccines Sales and Growth Rate (2014-2019)
6.6 Italy Toxoid Vaccines Sales and Growth Rate (2014-2019)
7 Asia-Pacific Toxoid Vaccines by Country
7.1 Asia-Pacific Toxoid Vaccines Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Toxoid Vaccines Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Toxoid Vaccines Revenue and Market Share by Country (2014-2019)
7.2 China Toxoid Vaccines Sales and Growth Rate (2014-2019)
7.3 Japan Toxoid Vaccines Sales and Growth Rate (2014-2019)
7.4 Korea Toxoid Vaccines Sales and Growth Rate (2014-2019)
7.5 India Toxoid Vaccines Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Toxoid Vaccines Sales and Growth Rate (2014-2019)
8 South America Toxoid Vaccines by Country
8.1 South America Toxoid Vaccines Sales, Revenue and Market Share by Country
8.1.1 South America Toxoid Vaccines Sales and Market Share by Country (2014-2019)
8.1.2 South America Toxoid Vaccines Revenue and Market Share by Country (2014-2019)
8.2 Brazil Toxoid Vaccines Sales and Growth Rate (2014-2019)
8.3 Argentina Toxoid Vaccines Sales and Growth Rate (2014-2019)
8.4 Colombia Toxoid Vaccines Sales and Growth Rate (2014-2019)
9 Middle East and Africa Toxoid Vaccines by Countries
9.1 Middle East and Africa Toxoid Vaccines Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Toxoid Vaccines Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Toxoid Vaccines Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Toxoid Vaccines Sales and Growth Rate (2014-2019)
9.3 Turkey Toxoid Vaccines Sales and Growth Rate (2014-2019)
9.4 Egypt Toxoid Vaccines Sales and Growth Rate (2014-2019)
9.5 Nigeria Toxoid Vaccines Sales and Growth Rate (2014-2019)
9.6 South Africa Toxoid Vaccines Sales and Growth Rate (2014-2019)
10 Global Toxoid Vaccines Market Segment by Type
10.1 Global Toxoid Vaccines Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Toxoid Vaccines Sales and Market Share by Type (2014-2019)
10.1.2 Global Toxoid Vaccines Revenue and Market Share by Type (2014-2019)
10.2 Monovalent Tetanus Toxoid (TT) Sales Growth and Price
10.2.1 Global Monovalent Tetanus Toxoid (TT) Sales Growth (2014-2019)
10.2.2 Global Monovalent Tetanus Toxoid (TT) Price (2014-2019)
10.3 Diphtheria Sales Growth and Price
10.3.1 Global Diphtheria Sales Growth (2014-2019)
10.3.2 Global Diphtheria Price (2014-2019)
10.4 Tetanus Sales Growth and Price
10.4.1 Global Tetanus Sales Growth (2014-2019)
10.4.2 Global Tetanus Price (2014-2019)
10.5 Pertussis (DTaP) Sales Growth and Price
10.5.1 Global Pertussis (DTaP) Sales Growth (2014-2019)
10.5.2 Global Pertussis (DTaP) Price (2014-2019)
10.6 Diphtheria and Tetanus (DT) Sales Growth and Price
10.6.1 Global Diphtheria and Tetanus (DT) Sales Growth (2014-2019)
10.6.2 Global Diphtheria and Tetanus (DT) Price (2014-2019)
11 Global Toxoid Vaccines Market Segment by Application
11.1 Global Toxoid Vaccines Sales Market Share by Application (2014-2019)
11.2 Hospitals And Clinics Sales Growth (2014-2019)
11.3 Government Organizations Sales Growth (2014-2019)
11.4 Research Sales Growth (2014-2019)
11.5 Others Sales Growth (2014-2019)
12 Toxoid Vaccines Market Forecast (2019-2024)
12.1 Global Toxoid Vaccines Sales, Revenue and Growth Rate (2019-2024)
12.2 Toxoid Vaccines Market Forecast by Regions (2019-2024)
12.2.1 North America Toxoid Vaccines Market Forecast (2019-2024)
12.2.2 Europe Toxoid Vaccines Market Forecast (2019-2024)
12.2.3 Asia-Pacific Toxoid Vaccines Market Forecast (2019-2024)
12.2.4 South America Toxoid Vaccines Market Forecast (2019-2024)
12.2.5 Middle East and Africa Toxoid Vaccines Market Forecast (2019-2024)
12.3 Toxoid Vaccines Market Forecast by Type (2019-2024)
12.3.1 Global Toxoid Vaccines Sales Forecast by Type (2019-2024)
12.3.2 Global Toxoid Vaccines Market Share Forecast by Type (2019-2024)
12.4 Toxoid Vaccines Market Forecast by Application (2019-2024)
12.4.1 Global Toxoid Vaccines Sales Forecast by Application (2019-2024)
12.4.2 Global Toxoid Vaccines Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

List of Tables and Figures

Figure Toxoid Vaccines Picture
Table Product Specifications of Toxoid Vaccines
Figure Global Sales Market Share of Toxoid Vaccines by Types in 2018
Table Toxoid Vaccines Types for Major Manufacturers
Figure Monovalent Tetanus Toxoid (TT) Picture
Figure Diphtheria Picture
Figure Tetanus Picture
Figure Pertussis (DTaP) Picture
Figure Diphtheria and Tetanus (DT) Picture
Figure Toxoid Vaccines Sales Market Share by Applications in 2018
Figure Hospitals And Clinics Picture
Figure Government Organizations Picture
Figure Research Picture
Figure Others Picture
Figure United States Toxoid Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Toxoid Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Toxoid Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Toxoid Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure France Toxoid Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure UK Toxoid Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Toxoid Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Toxoid Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure China Toxoid Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Toxoid Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Toxoid Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure India Toxoid Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Toxoid Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Toxoid Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Toxoid Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Toxoid Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Toxoid Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Toxoid Vaccines Revenue (Value) and Growth Rate (2014-2024)
Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline Toxoid Vaccines Type and Applications
Table GlaxoSmithKline Toxoid Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Toxoid Vaccines Type and Applications
Table Merck Toxoid Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Toxoid Vaccines Type and Applications
Table Pfizer Toxoid Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table Sanofi Pasteur Toxoid Vaccines Type and Applications
Table Sanofi Pasteur Toxoid Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Toxoid Vaccines Type and Applications
Table AstraZeneca Toxoid Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Bharat Biotech Basic Information, Manufacturing Base and Competitors
Table Bharat Biotech Toxoid Vaccines Type and Applications
Table Bharat Biotech Toxoid Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Shenzhen Kangtai Biological Products Basic Information, Manufacturing Base and Competitors
Table Shenzhen Kangtai Biological Products Toxoid Vaccines Type and Applications
Table Shenzhen Kangtai Biological Products Toxoid Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Valeant Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Valeant Pharmaceuticals Toxoid Vaccines Type and Applications
Table Valeant Pharmaceuticals Toxoid Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Emergent Biosolutions Basic Information, Manufacturing Base and Competitors
Table Emergent Biosolutions Toxoid Vaccines Type and Applications
Table Emergent Biosolutions Toxoid Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Astellas Pharma Basic Information, Manufacturing Base and Competitors
Table Astellas Pharma Toxoid Vaccines Type and Applications
Table Astellas Pharma Toxoid Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Panacea Biotec Basic Information, Manufacturing Base and Competitors
Table Panacea Biotec Toxoid Vaccines Type and Applications
Table Panacea Biotec Toxoid Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Toxoid Vaccines Sales by Manufacturer (2017-2018)
Figure Global Toxoid Vaccines Sales Market Share by Manufacturer in 2017
Figure Global Toxoid Vaccines Sales Market Share by Manufacturer in 2018
Table Global Toxoid Vaccines Revenue by Manufacturer (2017-2018)
Figure Global Toxoid Vaccines Revenue Market Share by Manufacturer in 2017
Figure Global Toxoid Vaccines Revenue Market Share by Manufacturer in 2018
Figure Top 3 Toxoid Vaccines Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Toxoid Vaccines Manufacturer (Revenue) Market Share in 2018
Figure Global Toxoid Vaccines Sales and Growth Rate (2014-2019)
Figure Global Toxoid Vaccines Revenue and Growth Rate (2014-2019)
Table Global Toxoid Vaccines Sales by Regions (2014-2019)
Table Global Toxoid Vaccines Sales Market Share by Regions (2014-2019)
Table Global Toxoid Vaccines Revenue by Regions (2014-2019)
Figure Global Toxoid Vaccines Revenue Market Share by Regions in 2014
Figure Global Toxoid Vaccines Revenue Market Share by Regions in 2018
Figure North America Toxoid Vaccines Sales and Growth Rate (2014-2019)
Figure Europe Toxoid Vaccines Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Toxoid Vaccines Sales and Growth Rate (2014-2019)
Figure South America Toxoid Vaccines Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Toxoid Vaccines Sales and Growth Rate (2014-2019)
Figure North America Toxoid Vaccines Revenue and Growth Rate (2014-2019)
Table North America Toxoid Vaccines Sales by Countries (2014-2019)
Table North America Toxoid Vaccines Sales Market Share by Countries (2014-2019)
Figure North America Toxoid Vaccines Sales Market Share by Countries in 2014
Figure North America Toxoid Vaccines Sales Market Share by Countries in 2018
Table North America Toxoid Vaccines Revenue by Countries (2014-2019)
Table North America Toxoid Vaccines Revenue Market Share by Countries (2014-2019)
Figure North America Toxoid Vaccines Revenue Market Share by Countries in 2014
Figure North America Toxoid Vaccines Revenue Market Share by Countries in 2018
Figure United States Toxoid Vaccines Sales and Growth Rate (2014-2019)
Figure Canada Toxoid Vaccines Sales and Growth Rate (2014-2019)
Figure Mexico Toxoid Vaccines Sales and Growth Rate (2014-2019)
Figure Europe Toxoid Vaccines Revenue and Growth Rate (2014-2019)
Table Europe Toxoid Vaccines Sales by Countries (2014-2019)
Table Europe Toxoid Vaccines Sales Market Share by Countries (2014-2019)
Table Europe Toxoid Vaccines Revenue by Countries (2014-2019)
Figure Europe Toxoid Vaccines Revenue Market Share by Countries in 2017
Figure Europe Toxoid Vaccines Revenue Market Share by Countries in 2018
Figure Germany Toxoid Vaccines Sales and Growth Rate (2014-2019)
Figure UK Toxoid Vaccines Sales and Growth Rate (2014-2019)
Figure France Toxoid Vaccines Sales and Growth Rate (2014-2019)
Figure Russia Toxoid Vaccines Sales and Growth Rate (2014-2019)
Figure Italy Toxoid Vaccines Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Toxoid Vaccines Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Toxoid Vaccines Sales by Countries (2014-2019)
Table Asia-Pacific Toxoid Vaccines Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Toxoid Vaccines Sales Market Share by Countries 2018
Table Asia-Pacific Toxoid Vaccines Revenue by Countries (2014-2019)
Figure Asia-Pacific Toxoid Vaccines Revenue Market Share by Countries 2018
Figure China Toxoid Vaccines Sales and Growth Rate (2014-2019)
Figure Japan Toxoid Vaccines Sales and Growth Rate (2014-2019)
Figure Korea Toxoid Vaccines Sales and Growth Rate (2014-2019)
Figure India Toxoid Vaccines Sales and Growth Rate (2014-2019)
Figure Southeast Asia Toxoid Vaccines Sales and Growth Rate (2014-2019)
Figure South America Toxoid Vaccines Revenue and Growth Rate (2014-2019)
Table South America Toxoid Vaccines Sales by Countries (2014-2019)
Table South America Toxoid Vaccines Sales Market Share by Countries (2014-2019)
Figure South America Toxoid Vaccines Sales Market Share by Countries in 2018
Table South America Toxoid Vaccines Revenue by Countries (2014-2019)
Table South America Toxoid Vaccines Revenue Market Share by Countries (2014-2019)
Figure South America Toxoid Vaccines Revenue Market Share by Countries in 2018
Figure Brazil Toxoid Vaccines Sales and Growth Rate (2014-2019)
Figure Argentina Toxoid Vaccines Sales and Growth Rate (2014-2019)
Figure Colombia Toxoid Vaccines Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Toxoid Vaccines Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Toxoid Vaccines Sales by Countries (2014-2019)
Table Middle East and Africa Toxoid Vaccines Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Toxoid Vaccines Sales Market Share by Countries in 2018
Table Middle East and Africa Toxoid Vaccines Revenue by Countries (2014-2019)
Table Middle East and Africa Toxoid Vaccines Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Toxoid Vaccines Revenue Market Share by Countries in 2014
Figure Middle East and Africa Toxoid Vaccines Revenue Market Share by Countries in 2018
Figure Saudi Arabia Toxoid Vaccines Sales and Growth Rate (2014-2019)
Figure UAE Toxoid Vaccines Sales and Growth Rate (2014-2019)
Figure Egypt Toxoid Vaccines Sales and Growth Rate (2014-2019)
Figure Nigeria Toxoid Vaccines Sales and Growth Rate (2014-2019)
Figure South Africa Toxoid Vaccines Sales and Growth Rate (2014-2019)
Table Global Toxoid Vaccines Sales by Type (2014-2019)
Table Global Toxoid Vaccines Sales Share by Type (2014-2019)
Table Global Toxoid Vaccines Revenue by Type (2014-2019)
Table Global Toxoid Vaccines Revenue Share by Type (2014-2019)
Figure Global Monovalent Tetanus Toxoid (TT) Sales Growth (2014-2019)
Figure Global Monovalent Tetanus Toxoid (TT) Price (2014-2019)
Figure Global Diphtheria Sales Growth (2014-2019)
Figure Global Diphtheria Price (2014-2019)
Figure Global Tetanus Sales Growth (2014-2019)
Figure Global Tetanus Price (2014-2019)
Figure Global Pertussis (DTaP) Sales Growth (2014-2019)
Figure Global Pertussis (DTaP) Price (2014-2019)
Figure Global Diphtheria and Tetanus (DT) Sales Growth (2014-2019)
Figure Global Diphtheria and Tetanus (DT) Price (2014-2019)
Table Global Toxoid Vaccines Sales by Application (2014-2019)
Table Global Toxoid Vaccines Sales Share by Application (2014-2019)
Figure Global Government Organizations Sales Growth (2014-2019)
Figure Global Research Sales Growth (2014-2019)
Figure Global Others Sales Growth (2014-2019)
Figure Global Toxoid Vaccines Sales, Revenue and Growth Rate (2019-2024)
Table Global Toxoid Vaccines Sales Forecast by Regions (2019-2024)
Table Global Toxoid Vaccines Market Share Forecast by Regions (2019-2024)
Figure North America Sales Toxoid Vaccines Market Forecast (2019-2024)
Figure Europe Sales Toxoid Vaccines Market Forecast (2019-2024)
Figure Asia-Pacific Sales Toxoid Vaccines Market Forecast (2019-2024)
Figure South America Sales Toxoid Vaccines Market Forecast (2019-2024)
Figure Middle East and Africa Sales Toxoid Vaccines Market Forecast (2019-2024)
Table Global Toxoid Vaccines Sales Forecast by Type (2019-2024)
Table Global Toxoid Vaccines Market Share Forecast by Type (2019-2024)
Table Global Toxoid Vaccines Sales Forecast by Application (2019-2024)
Table Global Toxoid Vaccines Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List


【掲載企業】

GlaxoSmithKline、Merck、Pfizer、Sanofi Pasteur、AstraZeneca、Bharat Biotech、Shenzhen Kangtai Biological Products、Valeant Pharmaceuticals、Emergent Biosolutions、Astellas Pharma、Panacea Biotec、

★調査レポート[トキソイドワクチンの世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）] (コード：GIR9101145)販売に関する免責事項を必ずご確認ください。
★調査レポート[トキソイドワクチンの世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 猫用ワクチンの世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9101182 / GlobalInfoResearch / 2019年9月10日 / 本調査レポートは、猫用ワクチンの世界市場について調べ、まとめました。種類別セグメントは、弱毒生ワクチン、コンジュゲートワクチン、不活化ワクチン、サブユニットワクチン、トキソイドワクチン、DNAワクチン、組換えワクチン等、用途別セグメントは、＜6ヶ月、≥6ヶ月等に区分しました。猫用ワクチンの世界市場概観、メーカー動向、メーカー別猫用ワクチンシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・猫用ワクチンの市場概観 ・猫用ワクチンの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・猫用ワクチンの企業別販売動向、市場シェア、市場集中度、競争動向 ・猫用ワクチンの世界市場規模 ・猫用ワクチンの北米市場分析（アメリカ、カナダ、メキシコ等） ・猫用ワクチンのアメリカ市場規模推移 ・猫用ワクチンのカナダ市場規模推移 ・猫用ワクチンのメキシコ市場規模推移 ・猫用ワクチンのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins, or one of its surface proteins.Cat Vaccines are kins of Vaccines for cats Scope of the Report: The worldwide market for Cat Vaccines is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study....
  • 犬用ワクチンの世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9101183 / GlobalInfoResearch / 2019年9月10日 / 本調査レポートは、犬用ワクチンの世界市場について調べ、まとめました。種類別セグメントは、弱毒生ワクチン、コンジュゲートワクチン、不活化ワクチン、サブユニットワクチン、トキソイドワクチン、DNAワクチン、組換えワクチン等、用途別セグメントは、...A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins, or one of its surface proteins.Cat Vaccines are kins of Vaccines for dogs Scope of the Report: The worldwide market for Dog Vaccines is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study....
  • 小児ワクチンの世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9100436 / GlobalInfoResearch / 2019年10月11日 / 本調査レポートは、小児ワクチンの世界市場について調べ、まとめました。種類別セグメントは、組換えワクチン、ウイルスワクチン、多糖ワクチン、その他等、用途別セグメントは、病院、クリニック等に区分しました。小児ワクチンの世界市場概観、メーカー動向、メーカー別小児ワクチンシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・小児ワクチンの市場概観 ・小児ワクチンの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・小児ワクチンの企業別販売動向、市場シェア、市場集中度、競争動向 ・小児ワクチンの世界市場規模 ・小児ワクチンの北米市場分析（アメリカ、カナダ、メキシコ等） ・小児ワクチンのアメリカ市場規模推移 ・小児ワクチンのカナダ市場規模推移 ・小児ワクチンのメキシコ市場規模推移 ・小児ワクチンのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）... Scope of the Report: The worldwide market for Childhood Vaccines is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Childhood Vaccines in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Market Segment by Manufacturers, this report covers MedImmune LLC J&J(Crucell) Pfizer Sanofi GSK Merck Tiantan CSL Jintan...
  • 新興癌ワクチンの世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9103455 / GlobalInfoResearch / 2019年9月26日 / 本調査レポートは、新興癌ワクチンの世界市場について調べ、まとめました。種類別セグメントは、非遺伝子ワクチン、遺伝子ワクチン等、用途別セグメントは、がん研究センター、がん病院、クリニック、その他等に区分しました。新興癌ワクチンの世界市場概観、メーカー動向、メーカー別新興癌ワクチンシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・新興癌ワクチンの市場概観 ・新興癌ワクチンの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・新興癌ワクチンの企業別販売動向、市場シェア、市場集中度、競争動向 ・新興癌ワクチンの世界市場規模 ・新興癌ワクチンの北米市場分析（アメリカ、カナダ、メキシコ等） ・新興癌ワクチンのアメリカ市場規模推移 ・新興癌ワクチンのカナダ市場規模推移 ・新興癌ワクチンのメキシコ市場規模推移 ・新興癌ワクチンのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Genetic vaccines are emerging as promising methodologies to elicit immune responses against a wide variety of antigens. Scope of the Report: The worldwide market for Emerging Cancer Vaccines is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Emerging Cancer Vaccines in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and...
  • オーエスキー病ワクチンの世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9100289 / GlobalInfoResearch / 2019年10月10日 / 本調査レポートは、オーエスキー病ワクチンの世界市場について調べ、まとめました。種類別セグメントは、凍結乾燥錠、注射剤等、用途別セグメントは、雌ブタ、子ブタ、イノシシ等に区分しました。オーエスキー病ワクチンの世界市場概観、メーカー動向、メーカー別オーエスキー病ワクチンシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・オーエスキー病ワクチンの市場概観 ・オーエスキー病ワクチンの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・オーエスキー病ワクチンの企業別販売動向、市場シェア、市場集中度、競争動向 ・オーエスキー病ワクチンの世界市場規模 ・オーエスキー病ワクチンの北米市場分析（アメリカ、カナダ、メキシコ等） ・オーエスキー病ワクチンのアメリカ市場規模推移 ・オーエスキー病ワクチンのカナダ市場規模推移 ・オーエスキー病ワクチンのメキシコ市場規模推移 ・オーエスキー病ワクチンのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）... Scope of the Report: The worldwide market for Aujeszky Disease Vaccines is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Aujeszky Disease Vaccines in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Market Segment by Manufacturers, this report covers Zendal group(CZ Vaccines) Kyoritsuseiyaku Corporation Ceva IDEXX MSD Animal...
  • RNAワクチンの世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9101166 / GlobalInfoResearch / 2019年9月10日 / 本調査レポートは、RNAワクチンの世界市場について調べ、まとめました。種類別セグメントは、個別がん治療MRNAワクチン、感染症治療MRNAワクチン、感染予防MRNAワクチン等、用途別セグメントは、感染症、がん、その他等に区分しました。RNAワクチンの世界市場概観、メーカー動向、メーカー別RNAワクチンシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・RNAワクチンの市場概観 ・RNAワクチンの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・RNAワクチンの企業別販売動向、市場シェア、市場集中度、競争動向 ・RNAワクチンの世界市場規模 ・RNAワクチンの北米市場分析（アメリカ、カナダ、メキシコ等） ・RNAワクチンのアメリカ市場規模推移 ・RNAワクチンのカナダ市場規模推移 ・RNAワクチンのメキシコ市場規模推移 ・RNAワクチンのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...RNA is a rather versatile technology and offers a number of advantages. RNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes RNA especially attractive for vaccines and gene editing. RNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of RNA has greatly favored the development of in vivo transfection strategies. RNA Vaccines & Therapeutics is in the development stage and there is no use in the market. The fastest research...

    • ◆H&Iグローバルリサーチのお客様（例）◆